Lakeside Holding Limited Seals $1.5 Million Deal with Sinopharm Subsidiary for Critical Medicines Lakeside Holding Limited has signed a significant sales agreement valued at $1.5 million with a Sinopharm subsidiary, focusing on vital medications in the Asia-Pacific region.

Lakeside Holding Limited Seals $1.5 Million Deal with Sinopharm Subsidiary for Critical Medicines #United_States #Itasca #Lakeside_Holding #Hupan_Pharmaceutical #Sinopharm_Group